OpenCapital
Earnings
Stock Screener
Metrics
/
Stocks
Connect AI
Toggle navigation menu
Stocks
ALN
Alnylam Pharmaceuticals
Balance Sheet Statement
Loss Contingency Accrual
Other
Loss Contingency Accrual
Export Chart
Analysis
Statement
Balance Sheet Statement
Section
Other
First reported
Q4 2024
Last reported
Q4 2025
Apr 30, 2026
Metric ID:
other_loss_contingency_accrual_at_carrying_value
Historical Data
2 periods
Quarterly
Annual
Q4 '24
Q4 '25
Value
$0.00
$0.00
Range
$0.00 – $0.00
Loss Contingency Accrual at Other Companies
Moderna
MRNA
View metric
Frequently Asked Questions
What is Alnylam Pharmaceuticals's loss contingency accrual?
Alnylam Pharmaceuticals (ALNY) reported loss contingency accrual of $0.00 in Q4 2025.